Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 31.4190.4644.6521.42-16.64

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 31.41 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202431.41
Mar202390.46
Mar202244.65
Mar202121.42
Mar2020-16.64

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 31.41
-65.28
Mar2023 90.46
102.60
Mar2022 44.65
108.45
Mar2021 21.42
Positive
Mar2020 -16.64 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹420.9 Cr 8.8% 10% 2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹119,919.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -2.6% -8.1% -4.9% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

8.8%

10%

2.6%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses